|
Rep. William E Hauter
Filed: 4/2/2024
| | 10300HB4055ham001 | | LRB103 31972 RPS 71661 a |
|
|
| 1 | | AMENDMENT TO HOUSE BILL 4055
|
| 2 | | AMENDMENT NO. ______. Amend House Bill 4055 by replacing |
| 3 | | everything after the enacting clause with the following:
|
| 4 | | "Section 5. The Prior Authorization Reform Act is amended |
| 5 | | by adding Section 77 as follows:
|
| 6 | | (215 ILCS 200/77 new) |
| 7 | | Sec. 77. Prior authorization for drug therapies for |
| 8 | | hereditary bleeding disorders. Notwithstanding any other |
| 9 | | provision of law, a health insurance issuer or a contracted |
| 10 | | utilization review organization may not require a prior |
| 11 | | authorization for drug therapies approved by the U.S. Food and |
| 12 | | Drug Administration for the treatment of hereditary bleeding |
| 13 | | disorders any more frequently than 6 months or the length of |
| 14 | | time the prescription for that dosage remains valid, whichever |
| 15 | | period is shorter.
|